Consulting Offerings for the Life Sciences Industry
Helping our clients lead and shape the global marketplace
With the life sciences marketplace shifting and evolving at an ever-increasing pace, pharmaceutical manufacturers, biotechnology firms and medical product, technology and device manufacturers should act promptly, responsibly and effectively to grow revenue and market share, even as industry dynamics drive increased focus on regulatory compliance, lower costs, innovation and network flexibility.
Deloitte Consulting LLP is helping our life sciences clients as they pursue growth opportunities and grapple with multiple scientific, business and regulatory challenges. Through our demonstrated/time-tested combination of industry experience and broad service offerings we are helping our clients lead and shape the global life sciences marketplace. Click here to read more about Deloitte Life Sciences Consulting.
|In the face of uncertainty - A challenging future for biopharmaceutical innovation
A recent Deloitte study has shown that the overall rate of return on R&D investment for the 12 largest biopharmaceutical firms has dropped significantly since 2010, and the cost of developing a new medicine has risen substantially. Learn more.
|Health Care Reform - Redefining biopharma innovation
Learn how reform will indirectly impact biopharma through changing stakeholder relationships.
|Prescribed behavior: Operating under a consent decree
Read the Pharmaceutical Executive magazine article.
|Operating under consent decree
Managing a Life Sciences company through a major regulatory action.
|Measuring the return from Pharmaceutical innovation 2013
Weathering the storm? Read our full report.
|Global HCP transparency study
This report provides guidance for life sciences companies on how to address global HCP transparency challenges.
Our solution areas
Finance Transformation in pharmaceuticals - From the F troop to the 82nd airborne
Could the finance function continue to lead business value and responsiveness – and improve efficiency at the same time?
Finance Transformation in pharmaceuticals: When the party's over
After years of record growth, declining profitability forced this large pharmaceutical company to increase its focus on efficiency and costs.
Human capital transformation helps multinational pharmaceutical companies through merger
Creating a comprehensive approach to human capital management.
Life Sciences company seeks improved HR service delivery
Developing and implementing a new Human Resources Service Delivery Model.
Life Sciences company seeks relief from growing pains, finds immediate $40 Million in Savings
Enterprise cost reduction in the medical device industry.
To read more client stories, click here.
Meet our leadership team
Principal, National Life Sciences Consulting Practice Leader
Principal, National Leader, LS Product Supply & Operations Practice
|Terri Cooper, Ph.D.
Principal, National Leader, Life Sciences R&D Practice
Principal, National Leader, Life Sciences M&A and Restructuring Practice
Principal, National Leader, Life Sciences IM/BA Practice
Principal, National Leader, Life Sciences HR Transformation Practice
Principal, National Leader, Life Sciences Commercial Practice
Principal, National Leader, Life Sciences CIO Services Practice
Principal, National Leader, Life Sciences Corporate Strategy Practice
Principal, National Leader, Life Sciences Finance Transformation Practice
Principal, National Leader, Life Sciences SAP Practice
Principal, National Leader, Life Sciences Oracle Practice
Principal, Medical Technology Segment Leader
Principal, Federal Health Segment Leader
As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.